MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4254/wjh.v18.i1.113753

Медицинская библиотека · World journal of hepatology · 2026

Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study.

Schwartz Andrew W, Park Emily Y, Ilagan-Ying Ysabel C, Zimmerman Zoe E, Bollinger Bryan, Ying Lee D, Deng Yanhong D, Duffy Andrew J, Morton John M, Mehal Wajahat Z, Do Albert, Banini Bubu A

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Lifestyle modifications aimed at weight loss are key to improving metabolic dysfunction-associated steatotic liver disease (MASLD); however, achieving substantial and sustained weight loss through non-surgical approaches may be difficult for some patients. Bariatric surgery should be considered as a therapeutic option in select patients with MASLD, but the national referral rate for eligible patients is low (< 1%).

AIM: To examine referral rates and one-year outcomes among adults with MASLD in a multidisciplinary clinic integrating hepatology and obesity medicine.

METHODS

We performed a retrospective cohort study of 965 patients seen in a MASLD-specific clinic over a three-year period (2018-2022). Patients were categorized as bariatric surgery eligible or non-eligible based on standard referral criteria. We assessed bariatric surgery referral rates, weight, and liver-related outcomes, including change in nonalcoholic fatty liver disease fibrosis score. Categorical variables were compared with χ 2 tests, and continuous variables were analyzed with two-tailed t-tests. P value < 0.05 was considered significant.

RESULTS

Among 491 patients eligible for bariatric surgery, 127 patients (26%) were referred for surgical evaluation, with 31 patients (24%) ultimately undergoing bariatric surgery (21 sleeve gastrectomy and 10 Roux-en-Y gastric bypass). The remaining 96 patients continued with medication and/or lifestyle management. Individuals who underwent bariatric surgery achieved greater one-year total body weight loss than those who utilized medication and/or lifestyle management alone (20.6% vs 2.5%, P < 0.001). Average nonalcoholic fatty liver disease fibrosis score at one year was -0.91 in surgery patients vs -0.008 in non-surgery patients (P = 0.005).

CONCLUSION

Integration of weight management with hepatology care in patients with MASLD resulted in bariatric surgery referral rates that substantially exceed the national average, leading to improved weight and liver-related outcomes.

Для цитирования: Schwartz Andrew W, Park Emily Y, Ilagan-Ying Ysabel C, Zimmerman Zoe E, Bollinger Bryan, Ying Lee D, Deng Yanhong D, Duffy Andrew J, Morton John M, Mehal Wajahat Z, Do Albert, Banini Bubu A. Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study.. World journal of hepatology. 2026. DOI: 10.4254/wjh.v18.i1.113753.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.